Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya

Objectives Herpes simplex virus type 2 (HSV-2) biomarkers are often used in adolescent sub-Saharan HIV prevention studies, but evaluations of test performance and disclosure outcomes are rare in the published literature. Therefore, we investigated the proportion of ELISA-positive and indeterminate samples confirmed by western blot (WB), the psychosocial response to disclosure and whether reports of sexual behaviour and HSV-2 symptoms are consistent with WB confirmatory results among adolescent orphans in Kenya. Methods In 2011, 837 Kenyan orphan youth in grades 7 and 8 enrolled in an HIV prevention clinical trial with HSV-2 biomarker outcomes. We used a modified algorithm for the Kalon HSV-2 ELISA to improve specificity; positive and indeterminate results were WB tested. We developed culturally sensitive protocols for disclosing positive results, and documented psychosocial responses, reports of sexual contact and HSV-2 symptoms. Results 28 adolescents (3.3%) were identified as HSV-2 seropositive, six as indeterminate. Of these, 22 positive and all indeterminates were WB tested; 20 and 5, respectively, were confirmed positive. Most youth reported moderate brief stress after disclosure; 22% reported longer and more severe distress. Boys were more likely to be in the latter category. Self-reported virginity was highly inconsistent with WB-confirmed positives. Conclusions The higher than manufacturer's cut-off for Kalon ELISA modestly reduced the rate of false-positive test results, but also increased false negatives. Investigators should consider the risk:benefit ratio in deciding whether or not to disclose HSV-2 results to adolescent participants under specific field conditions. Trial registration number NCT01501864.

[1]  D. Hallfors,et al.  Discordance of HIV and HSV-2 biomarkers and self-reported sexual behaviour among orphan adolescents in Western Kenya , 2014, Sexually Transmitted Infections.

[2]  D. Hallfors,et al.  Use of HIV and HSV-2 Biomarkers in Sub-Saharan Adolescent Prevention Research: A Comparison of Two Approaches , 2014, The Journal of Primary Prevention.

[3]  A. Mason-Jones,et al.  Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review , 2012, International journal of STD & AIDS.

[4]  R. Garfein,et al.  Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial , 2012, The Lancet.

[5]  R. Kaiser,et al.  Prevalence of Herpes Simplex Virus Type 2 Infection, Human Immunodeficiency Virus/Herpes Simplex Virus Type 2 Coinfection, and Associated Risk Factors in a National, Population-Based Survey in Kenya , 2011, Sexually transmitted diseases.

[6]  A. Wald,et al.  Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review , 2011, Sexually Transmitted Infections.

[7]  H. Weiss,et al.  Performance of Commercial Herpes Simplex Virus Type-2 Antibody Tests Using Serum Samples From Sub-Saharan Africa: A Systematic Review and Meta-analysis , 2011, Sexually transmitted diseases.

[8]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  R. Ferrand,et al.  Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Holmes,et al.  Performance of HSV-2 type specific serological tests in men in Kenya. , 2010, Journal of virological methods.

[11]  G. Mashavave,et al.  The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth , 2010, BMC women's health.

[12]  E. Paintsil,et al.  Association of Age at First Sex With HIV-1, HSV-2, and Other Sexual Transmitted Infections Among Women in Northern Tanzania , 2009, Sexually transmitted diseases.

[13]  H. Weiss,et al.  Herpes simplex virus type 2: a key role in HIV incidence. , 2009, AIDS.

[14]  Glynn,et al.  HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western Kenya , 2009, PloS one.

[15]  O. Laeyendecker,et al.  Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. , 2009, The Journal of infectious diseases.

[16]  J. Zenilman,et al.  Serologic Screening for Herpes Simplex Virus Among University Students: A Pilot Study , 2008, Journal of American college health : J of ACH.

[17]  S. Moses,et al.  Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing , 2008, Sexually Transmitted Infections.

[18]  Anne M Johnson,et al.  The Regai Dzive Shiri Project: a cluster randomised controlled trial to determine the effectiveness of a multi‐component community‐based HIV prevention intervention for rural youth in Zimbabwe – study design and baseline results , 2008, Tropical medicine & international health : TM & IH.

[19]  R. Jewkes,et al.  Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial , 2008, BMJ : British Medical Journal.

[20]  O. Laeyendecker,et al.  Improved Performance of Enzyme-Linked Immunosorbent Assays and the Effect of Human Immunodeficiency Virus Coinfection on the Serologic Detection of Herpes Simplex Virus Type 2 in Rakai, Uganda , 2008, Clinical and Vaccine Immunology.

[21]  Edward A. Smith,et al.  Inconsistent reports of sexual intercourse among South African high school students. , 2008, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[22]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[23]  S. G. Gundersen,et al.  Herpes simplex virus type 2 prevalence of epidemic proportions in rural Zimbabwean women: association with other sexually transmitted infections , 2005, Archives of Gynecology and Obstetrics.

[24]  R. Hayes,et al.  “A bit more truthful”: the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods , 2004, Sexually Transmitted Infections.

[25]  H. Weiss,et al.  Epidemiology of herpes simplex virus type 2 infection in the developing world. , 2004, Herpes : the journal of the IHMF.

[26]  W. Whittington,et al.  Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment , 2003, Sexually transmitted infections.

[27]  Gale R. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[28]  Anne M Johnson,et al.  School based HIV prevention in Zimbabwe: feasibility and acceptability of evaluation trials using biological outcomes , 2002, AIDS.

[29]  R L Ashley,et al.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera , 1988, Journal of clinical microbiology.

[30]  T. Miller,et al.  The impact of school subsidies on HIV-related outcomes among adolescent female orphans. , 2015, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[31]  Takashi Kawana,et al.  [Genital herpes]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.